Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-22-026832

President & CEO sold 297,573 shares at an average $12.94 ($3,851,918)

  • President & CEO acquired 297,573 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Stonehouse Jon P · President & CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2022-12-01 Exercise or conversion : show line 1 in the form +214,917 $1.42 $305,182 1,116,747 D
2022-12-01 Sale : show line 2 in the form −214,917 $13.00 $2,793,921 901,830 D
2022-12-02 Exercise or conversion : show line 3 in the form +82,656 $1.42 $117,372 984,486 D
2022-12-02 Sale : show line 4 in the form −82,656 $12.80 $1,057,997 901,830 D
Open-market sales · 297,573 sh · avg $12.94 · $3,851,918

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-12-01 Exercise or conversion : show line 5 in the form Emp. Stock Option (Right to Buy) −214,917 82,656 D
2022-12-02 Exercise or conversion : show line 6 in the form Emp. Stock Option (Right to Buy) −82,656 0 D
Loading xslF345X03/form4.xml…